Anti-BNIP1 antibodies are used in the immunodetection of the protein BCL2 interacting protein 1. In humans, the canonical protein has a reported length of 228 amino acid residues and a mass of 26.1 kDa. Its subcellular localization is in the mitochondria and ER. Up to 4 different isoforms have been reported for this protein. It is notably widely expressed in many tissue types. A member of the SEC20 protein family, BNIP1 is known to be involved with the apoptotic pathway. Post-translational modifications have been described, including ubiquitination. Synonyms for this target antigen include SEC20, TRG-8, vesicle transport protein SEC20, BCL2/adenovirus E1B 19 kDa protein-interacting protein 1, BCL2/adenovirus E1B 19kDa interacting protein 1, and NIP1. BNIP1 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. A number of BNIP1 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. In addition, Immunohistochemistry is also a common application.